LIMNW vs TWLO
Liminatus Pharma, Inc. Warrants (LIMNW) versus Twilio Inc (TWLO) — a side-by-side from cached financials, not a winner call.
Liminatus Pharma, Inc. Warrants (LIMNW) is a biotechnology company listed on US.
Twilio Inc (TWLO) is a software - infrastructure company listed on US.
LIMNW does not have a complete income-statement cache yet.
Latest reported TWLO revenue for 2026-06-30 was $2.91B. Net income was $1.16B. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
LIMNW currently screens at market cap $0. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
Not investment advice. Open the LIMNW and TWLO stock pages for the full models.
Not investment advice.